Cardiff Oncology (CRDF) Receivables - Net (2016 - 2025)
Cardiff Oncology (CRDF) has disclosed Receivables - Net for 15 consecutive years, with $182000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Net fell 76.46% to $182000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $182000.0 through Dec 2025, down 76.46% year-over-year, with the annual reading at $182000.0 for FY2025, 76.46% down from the prior year.
- Receivables - Net hit $182000.0 in Q4 2025 for Cardiff Oncology, down from $254000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $773000.0 in Q4 2024 to a low of $161000.0 in Q2 2023.
- Historically, Receivables - Net has averaged $441200.0 across 5 years, with a median of $426000.0 in 2022.
- Biggest five-year swings in Receivables - Net: skyrocketed 212.12% in 2024 and later plummeted 76.46% in 2025.
- Year by year, Receivables - Net stood at $535000.0 in 2021, then skyrocketed by 44.11% to $771000.0 in 2022, then crashed by 62.65% to $288000.0 in 2023, then skyrocketed by 168.4% to $773000.0 in 2024, then tumbled by 76.46% to $182000.0 in 2025.
- Business Quant data shows Receivables - Net for CRDF at $182000.0 in Q4 2025, $254000.0 in Q3 2025, and $526000.0 in Q2 2025.